As a portfolio company of Paragon Biosciences, Emalex is unceasing in its pursuit to improve the lives of people living with central nervous system (CNS) disorders through meaningful scientific breakthroughs.
Our leadership team is comprised of remarkable professionals who are passionate about innovative solutions that improve the lives of people living with chronic central nervous system conditions.
Frederick Munschauer, M.D., MSc., FAAN
Chief Medical Officer, Neurology and
Senior Vice President, Medical and
George Karkanias, Ph.D., MBA, MSc.
Associate Vice President, Global Head of Medical and Scientific Affairs